Status:

COMPLETED

Salbutamol Administration by Nebulizer Versus Metered Dose Inhaler With Spacer in Asthma in Children

Lead Sponsor:

Suez Canal University

Conditions:

Bronchial Asthma

Eligibility:

All Genders

2-14 years

Phase:

PHASE3

Brief Summary

Asthma is a problem that affects many children and affects their physical health in addition to having a social and financial burden on individuals, families and healthcare systems. In our pediatric e...

Detailed Description

Primary Objective: To determine whether the administration of a B2 agonist by metered dose inhaler with spacer is as effective as the administration of B2 agonist by nebulizer for the treatment of an...

Eligibility Criteria

Inclusion

  • Children ranging from 2 - 14 years old.
  • Both genders will be included.
  • Patients with an acute exacerbation of asthma.

Exclusion

  • Patients with arrhythmia and cardiac diseases.
  • Patients with thyroid diseases.
  • Patients with bronchiolitis, pneumonia. Patients with status asthmaticus requiring immediate pediatric intensive care unit hospitalization.

Key Trial Info

Start Date :

May 15 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2019

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03816267

Start Date

May 15 2018

End Date

March 31 2019

Last Update

April 4 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Suez Canal University Hospital

Ismailia, Egypt, 11411

Salbutamol Administration by Nebulizer Versus Metered Dose Inhaler With Spacer in Asthma in Children | DecenTrialz